4553 — Towa Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual cashflow statement for Towa Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	20,709	18,728	22,246	4,605	24,459
Depreciation
Amortisation
Non-Cash Items	-3,862	2,526	-2,350	1,914	-5,433
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-5,966	-19,325	-8,721	-23,383	-28,701
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	19,166	12,354	22,129	2,545	8,213
Capital Expenditures	-4,670	-9,879	-13,576	-30,469	-39,325
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-34,871	779	-46,153	185	-1,069
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-39,541	-9,100	-59,729	-30,284	-40,394
Financing Cash Flow Items	-1	-29	-26	-156	21
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	11,748	184	46,540	17,481	35,407
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-7,938	4,199	9,915	-8,573	5,393